Sanofi Consumer Healthcare India Q2 profit rises 13% as EBITDA margin reaches 37.9%
Sanofi Consumer Healthcare India reported Q2 net profit of ₹68.8 crore, up 13.3% year on year. Revenue grew 6.7% to ₹235.7 crore, supported by 12% domestic-sales growth and product relaunches, while EBITDA rose 27.2%.
Sanofi Consumer Healthcare India’s Q2 profit rose 13.3% to ₹68.8 crore as domestic sales grew 12%, aided by product relaunches. Revenue rose 6.7%, while EBITDA margin expanded 610 basis points to 37.9%, reflecting stronger go-to-market execution and brand investments.
Why this matters
No related recent signals are listed. Sanofi Consumer Healthcare India’s Q2 results show profit and EBITDA growth outpacing revenue growth, supported by domestic sales and product relaunches.
Retail-company signals are accelerating, up 396333% QoQ.